Urine arsenic concentrations and species excretion patterns in American Indian communities over a 10-year period: The strong heart study

Environmental Health Perspectives

Volumn 117, Issue 9, 2009, Pages 1428-1433

  Navas Acien, Ana ^a,b   Umans, Jason G ^c   Howard, Barbara V ^c   Goessler, Walter ^d   Francesconi, Kevin A ^d   Crainiceanu, Ciprian M ^a   Silbergeld, Ellen K ^a   Guallar, Eliseo ^b,e  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c MEDSTAR RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF GRAZ   (Austria)

^e CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

American Indians; Analytical chemistry; Arsenic; Arsenic species; Arsenobetaine; Exposure assessment; Metabolism; Mixed effects models; Multilevel analysis; Strong Heart Study

Indexed keywords

ARSENIC; ARSENIC ACID; ARSENIC TRIOXIDE; ARSENOBETAINE; CACODYLIC ACID; DRINKING WATER; METHANEARSONIC ACID;

ADULT; AGED; AMERICAN INDIAN; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; UNITED STATES; URINALYSIS; URINARY EXCRETION; URINE LEVEL; WATER CONTAMINATION;

AGED; ARSENIC; COHORT STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; MALE; MIDDLE AGED; UNITED STATES;

EID: 69949108531     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0800509     Document Type: Article

References (58)

1. American Conference of Governmental Industrial Hygienists. 2004. Documentation of the Threshold Limit Values (TLV) and Biological Exposure Indices (BEI). Cincinnati, OH:ACGIH Worldwide.
2. Aposhian HV, Aposhian MM. 2006. Arsenic toxicology: five questions. Chem Res Toxicol 19:1-15.
3. Calderon RL, Hudgens E, Le XC, Schreinemachers D, Thomas DJ. 1999. Excretion of arsenic in urine as a function of exposure to arsenic in drinking water. Environ Health Perspect 107:663-667.
4. Caldwell KL, Jones RL, Verdon CP, Jarrett JM, Caudill SP, Osterloh JD. 2009. Levels of urinary total and speciated arsenic in the US population: National Health and Nutrition Examination Survey 2003-2004. J Expo Sci Environ Epidemiol 19:59-68.
5. Chen Y, van Geen A, Graziano JH, Pfaff A, Madajewicz M, Parvez F, et al. 2007. Reduction in urinary arsenic levels in response to arsenic mitigation efforts in Araihazar, Bangladesh. Environ Health Perspect 115:917-923.
6. Chen YC, Amarasiriwardena CJ, Hsueh YM, Christiani DC. 2002. Stability of arsenic species and insoluble arsenic in human urine. Cancer Epidemiol Biomarkers Prev 11:1427-1433.
7. Chen YC, Guo YL, Su HJ, Hsueh YM, Smith TJ, Ryan LM, et al. 2003a. Arsenic methylation and skin cancer risk in southwestern Taiwan. J Occup Environ Med 45:241-248.
8. Chen YC, Su HJ, Guo YL, Houseman EA, Christiani DC. 2005. Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer. Cancer Causes Control 16:75-81.
9. Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM, et al. 2003b. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 14:303-310.
10. Chiou HY, Hsueh YM, Hsieh LL, Hsu LI, Hsu YH, Hsieh FI, et al. 1997. Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat Res 386:197-207.
11. Concha G, Vogler G, Nermell B, Vahter M. 2002. Intra-individual variation in the metabolism of inorganic arsenic. Int Arch Occup Environ Health 75:576-580.
12. Cullen WR, Reimer KJ. 1989. Arsenic speciation in the environment. Chem Rev 89:713-764.
13. Del Razo LM, Garcia-Vargas GG, Garcia-Salcedo J, Sanmiguel MF, Rivera M, Hernandez MC, et al. 2002. Arsenic levels in cooked food and assessment of adult dietary intake of arsenic in the Region Lagunera, Mexico. Food Chem Toxicol 40:1423-1431.
14. Del Razo LM, Garcia-Vargas GG, Vargas H, Albores A, Gonsebatt ME, Montero R, et al. 1997. Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. A pilot study. Arch Toxicol 71:211-217.
15. Feldmann J, Lai VW, Cullen WR, Ma M, Lu X, Le XC. 1999. Sample preparation and storage can change arsenic speciation in human urine. Clin Chem 45:1988-1997.
16. Focazio MJ, Welch AH, Watkins SA, Helsel DR, Horn MA. 2000. A Retrospective Analysis on the Occurrence of Arsenic in Ground-Water Resources of the United States and Limitations in Drinking Water-Supply Characterizations. U.S. Geological Survey Water-Resources Investigations Report 99-4279. Reston, VA:U.S. Geological Survey.
17. Francesconi KA, Kuehnelt D. 2004. Determination of arsenic species: a critical review of methods and applications, 2000-2003. Analyst 129:373-395.
18. George CM, Smith AH, Kalman DA, Steinmaus CM. 2006. Reverse osmosis filter use and high arsenic levels in private well water. Arch Environ Occup Health 61:171-175.
19. Hansen HR, Raab A, Francesconi KA, Feldmann I. 2003. Metabolism of arsenic by sheep chronically exposed to arseno sugars as a normal part of their diet. 1. Quantitative intake, uptake, and excretion. Environ Sci Technol 37:845-851.
20. Hopenhayn-Rich C, Biggs ML, Kalman DA, Moore LE, Smith AH. 1996a. Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water. Environ Health Perspect 104:1200-1207.
21. Hopenhayn-Rich C, Biggs ML, Smith AH, Kalman DA, Moore LE. 1996b. Methylation study of a population environmentally exposed to arsenic in drinking water. Environ Health Perspect 104:620-628.
22. Howard BV, Lee ET, Cowan LD, Devereux RB, Galloway JM, Go OT, et al. 1999. Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. Circulation 99:2389-2395.
23. Hsueh YM, Chiou HY, Huang YL, Wu WL, Huang CC, Yang MH, et al. 1997. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol Biomarkers Prev 6:589-596.
24. Hsueh YM, Ko YF, Huang YK, Chen HW, Chiou HY, Huang YL, et al. 2003. Determinants of inorganic arsenic methylation capability among residents of the Lanyang Basin, Taiwan: arsenic and selenium exposure and alcohol consumption. Toxicol Lett 137:49-63.
25. Hughes MF. 2006. Biomarkers of exposure: a case study with inorganic arsenic. Environ Health Perspect 114:1790-1796.
26. International Agency for Research on Cancer. 2004. Some drinking-water disinfectants and contaminants, including arsenic. IARC Monogr Eval Carcinog Risks Hum 84:1-477.
27. Karagas MR, Le CX, Morris S, Blum J, Lu X, Spate V, et al. 2001. Markers of low level arsenic exposure for evaluating human cancer risks in a US population. Int J Occup Med Environ Health 14:171-175.
28. Kile ML, Hoffman E, Hsueh YM, Afroz S, Quamruzzaman Q, Rahman M, et al. 2009. Variability in biomarkers of arsenic exposure and metabolism in adults over time. Environ Health Perspect 117:455-460.
29. Lee ET, Welty TK, Fabsitz R, Cowan LD, Le NA, Oopik AJ, et al. 1990. The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol 132:1141-1155.
30. Liang KY, Zeger SL. 1986. Longitudinal data-analysis using generalized linear-models. Biometrika 73:13-22.
31. Lindberg AL, Ekstrom EC, Nermell B, Rahman M, Lonnerdal B, Persson LA, et al. 2008. Gender and age differences in the metabolism of inorganic arsenic in a highly exposed population in Bangladesh. Environ Res 106:110-120.
32. Lindberg AL, Goessler W, Gurzau E, Koppova K, Rudnai P, Kumar R, et al. 2006. Arsenic exposure in Hungary, Romania and Slovakia. J Environ Monit 8:203-208.
33. Loffredo CA, Aposhian HV, Cebrian ME, Yamauchi H, Silbergeld EK. 2003. Variability in human metabolism of arsenic. Environ Res 92:85-91.
34. Maki-Paakkanen J, Kurttio P, Paldy A, Pekkanen J. 1998. Association between the clastogenic effect in peripheral lymphocytes and human exposure to arsenic through drinking water. Environ Mol Mutagen 32:301-313.
35. National Research Council. 1999. Arsenic in Drinking Water. Washington, DC:National Academy Press.
36. National Toxicology Program. 2002. Tenth Report on Carcinogens. Research Triangle Park, NC:National Toxicology Program.
37. Navas-Acien A, Sharrett AR, Silbergeld EK, Schwartz BS, Nachman KE, Burke TA, et al. 2005. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol 162:1037-1049.
38. Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E. 2008. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 300:814-822.
39. Navas-Acien A, Silbergeld EK, Streeter RA, Clark JM, Burke TA, Guallar E. 2006. Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence. Environ Health Perspect 114:641-648.
40. Raml R, Goessler W, Traar P, Ochi T, Francesconi KA. 2005. Novel thioarsenic metabolites in human urine after ingestion of an arsenosugar, 2′,3′-dihydroxypropyl 5-deoxy-5-dimethyl-arsinoyl -beta-d-riboside. Chem Res Toxicol 18:1444-1450.
41. Raml R, Rumpler A, Goessler W, Vahter M, Li L, Ochi T, et al. 2007. Thio-dimethylarsinate is a common metabolite in urine samples from arsenic-exposed women in Bangladesh. Toxicol Appl Pharmacol 222:374-380.
42. Ryan PB, Huet N, MacIntosh DL. 2000. Longitudinal investigation of exposure to arsenic, cadmium, and lead in drinking water. Environ Health Perspect 108:731-735.
43. Smedley PL, Kinniburgh DG. 2002. A review of the source, behaviour and distribution of arsenic in natural waters. Appl Geochem 17:517-568.
44. Stang J, Zephier EM, Story M, Himes JH, Yeh JL, Welty T, et al. 2005. Dietary intakes of nutrients thought to modify cardiovascular risk from three groups of American Indians: the Strong Heart Dietary Study, phase II. J Am Diet Assoc 105:1895-1903.
45. States JC, Srivastava S, Chen Y, Barchowsky A. 2009. Arsenic and cardiovascular disease. Toxicol Sci 107(2):312-323.
46. Steinmaus C, Bates MN, Yuan Y, Kalman D, Atallah R, Rey OA, et al. 2006. Arsenic methylation and bladder cancer risk in case-control studies in Argentina and the United States. J Occup Environ Med 48:478-488.
47. Steinmaus C, Carrigan K, Kalman D, Atallah R, Yuan Y, Smith AH. 2005a. Dietary intake and arsenic methylation in a U.S. population. Environ Health Perspect 113:1153-1159.
48. Steinmaus C, Yuan Y, Kalman D, Atallah R, Smith AH. 2005b. Intraindividual variability in arsenic methylation in a U.S. population. Cancer Epidemiol Biomarkers Prev 14:919-924.
49. Steinmaus CM, Yuan Y, Smith AH. 2005c. The temporal stability of arsenic concentrations in well water in western Nevada. Environ Res 99:164-168.
50. Strong Heart Study. 2008. The Strong Heart Study: Largest Epidemiologic Study of Cardiovascular Disease in American Indians: Phase I Exam (SHS-I, the Baseline Examination). Available: http://strongheart.ouhsc.edu/#_Phase_I_Exam [accessed 1 March 2009].
51. Tobin J. 1958. Estimation of relationships for limited dependent-variables. Econometrica 26:24-36.
52. Tseng CH, Huang YK, Huang YL, Chung CJ, Yang MH, Chen CJ, et al. 2005. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol Appl Pharmacol 206:299-308.
53. U.S. EPA. 2001. National primary drinking water regulations; arsenic and clarifications to compliance and new source contaminants monitoring; final rule. Fed Reg 66:6976-7066.
54. Vahter M. 2000. Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol Lett 112-113:209-217.
55. Vahter M. 2002. Mechanisms of arsenic biotransformation. Toxicology 181-182:211-217.
56. Wu MM, Chiou HY, Hsueh YM, Hong CT, Su CL, Chang SF, et al. 2006. Effect of plasma homocysteine level and urinary monomethylarsonic acid on the risk of arsenic-associated carotid atherosclerosis. Toxicol Appl Pharmacol 216:168-175.
57. Yu RC, Hsu KH, Chen CJ, Froines JR. 2000. Arsenic methylation capacity and skin cancer. Cancer Epidemiol Biomarkers Prev 9:1259-1262.
58. Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Selvin S, Liaw J, et al. 2007. Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am J Epidemiol 166:1381-1391.